|
|
||||||||
J Thorac Cardiovasc Surg 2005;129:1197
© 2005 The American Association for Thoracic Surgery
Letters to the Editor |
a Department of Cardiothoracic Surgery, St Thomas Hospital, London, United Kingdom
b Department of Cardiology, St Thomas Hospital, London, United Kingdom
| The first 20% of the full text of this article appears below. |
To the Editor:
Antiplatelet therapy remains a topic of much-deserved attention and debate. We read with interest the recent article by Lim and associates1 in which they found that clopidogrel after coronary artery bypass grafting failed to inhibit platelet function, on the basis of the percentage platelet aggregation on day 5. Patients were randomized to receive 100 or 325 mg of aspirin daily or
This article has been cited by other articles:
![]() |
R. Hall and C. D. Mazer Review Article: Antiplatelet Drugs: A Review of Their Pharmacology and Management in the Perioperative Period Anesth. Analg., February 1, 2011; 112(2): 292 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bjessmo Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Ann. Thorac. Surg., October 1, 2009; 88(4): 1148 - 1152. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |